C-Rad AB (FRA:24C)
€ 3.18 +0.060 (+1.92%) Market Cap: 108.90 Mil Enterprise Value: 97.12 Mil PE Ratio: 25.10 PB Ratio: 3.34 GF Score: 95/100

Q4 2020 C Rad AB Earnings Call Transcript

Jan 28, 2021 / 10:00AM GMT
Tim Thurn;publ;CEO;President
C-Rad AB

()-&

Good morning, everyone. Today's webcast is presented to you by Henrik Bergentoft, our CFO; and me, Tim Thurn, the CEO. In the first part, I will give a short introduction and comment on the financial highlights in Q4 and for the full year 2020.

Let's look into our assessment of the sales development before I finish commenting on the key events. Henrik will guide you through the financial review before I conclude with a short presentation to give a market overview. At the end of the presentation, there will be a Q&A session. You can post your questions through the chat function, and we are happy to answer them before we close this webcast. And like always, we will put a recorded version of this webcast on our website after the meeting.

Let's get started with an introduction in the financial highlights. C-RAD is active in the field of cancer treatment. Our customers are hospitals that fight cancer with radiation. A modern, high-precision radiation therapy, accurate tumor alignment is crucial

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot